Tricyclic antidepressant-induced extrapyramidal side effects

• Published in: European neuropsychopharmacology Vol. 7; no. 3; pp. 207 - 212
• Main Authors: Vandel, P, Bonin, B, Leveque, E, Sechter, D, Bizouard, P
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.1997
• Subjects: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic - adverse effects; Antidepressive Agents, Tricyclic - therapeutic use; Basal Ganglia Diseases - chemically induced; Basal Ganglia Diseases - psychology; Depressive Disorder - complications; Depressive Disorder - drug therapy; Extrapyramidal side effects; Female; Humans; Male; Middle Aged; Tricyclic antidepressants; Tricyclic antidepressants; Extrapyramidal side effects
• DOI: 10.1016/S0924-977X(97)00405-7
• ISSN: 0924-977X

Two cases of tricyclic antidepressant-related extrapyramidal side effects are reported and, the authors review the literature describing these effects. Despite clear case reports, these side effects are not well known. Given the wide prescription of tricyclic antidepressants (TCA) and the low number of case reports, the prevalence of these side effects is indeed low, but clinical implications exist. The extrapyramidal symptoms induced by TCA alone are acute or tardive dyskinesia, akathisia, myoclonus, rabbit syndrome and dystonia. These symptoms seem to be non age-related, but often dose-related, and were responders to antiparkinsonian agents or propranolol. The factors that predispose an individual to the development of these side effects are not completely understood. Some risk factors such as prior exposure to neuroleptics and/or lithium or estrogens could facilitate the development of these side effects. In some cases, they can disappear even though the same dose of TCA is continued, and they do not seem to be a drug class reaction. The susceptibility of each individual patient to the development of these disorders may be limited to only one or a few of these agents.